ImportantUpdates
Windlas Biotech's Codeine cough syrup production is temporarily suspended after a Show Cause Notice from drug authorities.
Windlas Biotech LimitedWINDLAS · Filed with the exchange
This product line contributed Rs. 55.21 Cr to current FY revenue.
Only Codeine-based syrups are affected; other production continues normally.
No comments yet. Be the first.